Overview:
The
Medical Crossfire®, one of PER’s signature educational formats, is a
video-based program in which a panel of distinguished experts engage in spirted
discussions and debates on a particular clinical topic. In this activity, 3 key thought leaders explore the
latest data regarding the role of menin inhbitors in the treatment of acute
myeloid leukemia (AML). This lively discussion will help place new developments
into clinical context to help you optimize care for your patients with AML.
Learning Objectives:
Upon completion of this activity, participants will be able to:
- Determine the mechanistic rationale supporting the role of menin inhibitors in AML treatment
- Discuss the potential implications of recent trial evidence and emerging monotherapy/combination therapy trials evaluating menin inhibitors in patients with AML
- Develop individualized care plans for patients with NPM1m and/or KMT2A-r AML based on clinical trial evidence
- Devise strategies to proactively monitor and mitigate treatment-related toxicities and/or treatment resistance in patients with AML receiving menin inhibitors
Naval G. Daver, MD
Professor of Medicine
The University of Texas MD Anderson Cancer Center
Director- Leukemia Research Alliance Program
Houston, TX
Eunice Wang, MD
Chief, Leukemia Service
Medical Director, Chemotherapy/Infusion Center
Roswell Park Comprehensive Cancer Center
Buffalo, NY
Courtney DiNardo, MD
Professor of Medicine
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, TX
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.
Physicians' Education Resource®, LLC (PER) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Physicians' Education Resource®, LLC has approved this application-based activity for 1.50 ACPE CE hours UAN # 0661-0000-26-001-L01-P. Eligibility for credits requires full attendance, engagement in the live activity, completion and submission of the learner NABP ID # and month and day of birth, activity pre/post-session questions, and the post activity evaluation.